116 related articles for article (PubMed ID: 22905363)
1. Response to comment on "prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)".
Oyella J; Meya D; Bajunirwe F; Kamya MR
J Int AIDS Soc; 2012; 15(2):18003. PubMed ID: 22905363
[No Abstract] [Full Text] [Related]
2. Comment on "cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)".
Joob B; Wiwanitkit V
J Int AIDS Soc; 2012; 15(2):17977. PubMed ID: 22905364
[No Abstract] [Full Text] [Related]
3. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.
Oyella J; Meya D; Bajunirwe F; Kamya MR
J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404
[TBL] [Abstract][Full Text] [Related]
4. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M
Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.
Derbie A; Mekonnen D; Woldeamanuel Y; Abebe T
BMC Infect Dis; 2020 Jun; 20(1):407. PubMed ID: 32527231
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort.
Patel S; Shin GY; Wijewardana I; Vitharana SR; Cormack I; Pakianathan M; Harrison TS; Bicanic T
J Infect; 2013 Jan; 66(1):75-9. PubMed ID: 23046967
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Cryptococcal Antigenemia and associated factors among HIV/AIDS patients on second-line antiretroviral therapy at two hospitals in Western Oromia, Ethiopia.
Geda N; Beyene T; Dabsu R; Mengist HM
PLoS One; 2019; 14(12):e0225691. PubMed ID: 31805085
[TBL] [Abstract][Full Text] [Related]
9. Preventing deaths from cryptococcal meningitis: from bench to bedside.
Roy M; Chiller T
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou/Benin].
Ogouyèmi-Hounto A; Zannou DM; Ayihounton G; Ahouada C; Azon-Kouanou A; Acakpo J; Sissinto Savi de Tove Y; Kinde Gazard D
J Mycol Med; 2016 Dec; 26(4):391-397. PubMed ID: 27641486
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
13. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
Wadhwa A; Kaur R; Bhalla P
Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
[TBL] [Abstract][Full Text] [Related]
14. [Cryptococcal meningitis in HIV-infected patients at Bobo-Dioulasso hospital (Burkina Faso)].
Millogo A; Ki-Zerbo GA; Andonaba JB; Lankoandé D; Sawadogo A; Yaméogo I; Sawadogo AB
Bull Soc Pathol Exot; 2004 May; 97(2):119-21. PubMed ID: 15255356
[TBL] [Abstract][Full Text] [Related]
15. Immune correlates of HIV-associated cryptococcal meningitis.
Tenforde MW; Scriven JE; Harrison TS; Jarvis JN
PLoS Pathog; 2017 Mar; 13(3):e1006207. PubMed ID: 28334020
[No Abstract] [Full Text] [Related]
16. Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co-infection.
Okurut S; Boulware DR; Olobo J; Meya DB
Mycoses; 2020 Aug; 63(8):840-853. PubMed ID: 32472727
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.
Kambugu A; Meya DB; Rhein J; O'Brien M; Janoff EN; Ronald AR; Kamya MR; Mayanja-Kizza H; Sande MA; Bohjanen PR; Boulware DR
Clin Infect Dis; 2008 Jun; 46(11):1694-701. PubMed ID: 18433339
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal meningitis in AIDS patients: an emerging opportunistic infection in Senegal.
Hovette P; Soko TO; Raphenon G; Camara P; Burgel PR; Garraud O
Trans R Soc Trop Med Hyg; 1999; 93(4):368. PubMed ID: 10674078
[No Abstract] [Full Text] [Related]
19. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
Micol R; Lortholary O; Sar B; Laureillard D; Ngeth C; Dousset JP; Chanroeun H; Ferradini L; Guerin PJ; Dromer F; Fontanet A
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):555-9. PubMed ID: 17577124
[TBL] [Abstract][Full Text] [Related]
20. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ
J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
